Bio Pharma Dive
AUGUST 28, 2024
Under a collaboration with NextRNA Therapeutics, Bayer will access the biotech’s platform to target long, non-coding RNA interactions with small molecule drugs.
AuroBlog - Aurous Healthcare Clinical Trials blog
AUGUST 28, 2024
Federation of Asian Biotech Associations’ (FABA) Life Sciences Innovation Cluster is now working to strengthen the global partnerships to propel an ecosystem for novel biologics and diagnostics.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Bio Pharma Dive
AUGUST 28, 2024
Despite “positive” results, shares of the biotech slid by 20%. Analysts cautioned that Neurocrine shouldn’t get “the benefit of the doubt” with its data.
Pharma Times
AUGUST 28, 2024
The partnership will improve care for patients with pancreatic cancer
Speaker: Simran Kaur, Co-founder & CEO at Tattva Health Inc.
AI is transforming clinical trials—accelerating drug discovery, optimizing patient recruitment, and improving data analysis. But its impact goes far beyond research. As AI-driven innovation reshapes the clinical trial process, it’s also influencing broader healthcare trends, from personalized medicine to patient outcomes. Join this new webinar featuring Simran Kaur for an insightful discussion on what all of this means for the future of healthcare!
Bio Pharma Dive
AUGUST 28, 2024
By rejecting the first MDMA therapy this month, the FDA signaled to the psychedelic drug field that the road to approval isn’t easy.
Pharma Times
AUGUST 28, 2024
However the company will not continue developing the candidate
Clinical Research Informer brings together the best content for clinical researchers from the widest variety of industry thought leaders.
pharmaphorum
AUGUST 28, 2024
The £400m pledged by industry as part of the new VPAG voluntary scheme of pharma rebates will be used mainly to support the UK clinical research sector
Pharmaceutical Technology
AUGUST 28, 2024
The FDA also plans to hold an advisory committee for the DCCR therapy for Prader-Willi syndrome, with a PDUFA date of 27 December 2024.
pharmaphorum
AUGUST 28, 2024
A virtual voice assistant used to contact patients after heart procedures can make early discharge possible and spot complications
Pharmaceutical Technology
AUGUST 28, 2024
The European Commission has authorised Astellas Pharma's PADCEV regimen for the first-line treatment of advanced urothelial cancer.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Pharmaceutical Commerce
AUGUST 28, 2024
Session uncovers distributors’ experiences with the Waiver, Exception, or Exemption request process, and how these affect the overall supply chain.
Pharmaceutical Technology
AUGUST 28, 2024
Navigator Medicines has secured $100m in a Series A financing round with the aim of advancing bispecific antibody therapeutics.
Fierce Pharma
AUGUST 28, 2024
The rightsizing at BioMarin continues to take its toll as CEO Alexander Hardy devises a new corporate strategy for the rare disease biotech. | The rightsizing at BioMarin continues to take its toll as CEO Alexander Hardy devises a new corporate strategy for the rare disease biotech.
Pharmaceutical Technology
AUGUST 28, 2024
With new oesophageal cancer cases annually projected to increase by 80% before 2050, find out more about current and developing treatments.
Pharmaceutical Commerce
AUGUST 28, 2024
The latest news for pharma industry insiders.
Pharmaceutical Technology
AUGUST 28, 2024
Eli Lilly has announced the availability of Zepbound (tirzepatide) in 2.5mg and 5mg single-dose vials for self-pay for adults with obesity.
pharmaphorum
AUGUST 28, 2024
Changing Faces announces new board of directors appointments from July 2024 for Immatics, Memo Therapeutics, Scancell, Abcuro and more. Stay updated on the latest developments in the biotech industry.
Pharmaceutical Technology
AUGUST 28, 2024
Pfizer has launched a new digital platform, PfizerForAll, aimed at simplifying the process of accessing healthcare for millions of Americans.
Advertisement
White paper that delves into the complex topic of Decentralized Clinical Trials and how to master them within the confines of FDA Regulations
pharmaphorum
AUGUST 28, 2024
Lilly launches single-dose Zepbound to ease self-pay access Phil.
Fierce Pharma
AUGUST 28, 2024
Novartis has formed a strategic collaboration with drug delivery specialist Lindy Biosciences to develop self-administered versions of the Swiss pharma’s innovative drugs. | Novartis has formed a strategic collaboration with drug delivery specialist Lindy Biosciences to develop self-administered versions of the Swiss pharma’s innovative drugs.
pharmaphorum
AUGUST 28, 2024
Novartis builds case for fast-growing cholesterol drug Leqvio, as V-MONO trial shows benefit as a monotherapy in patients at lower risk of heart disease
Fierce Pharma
AUGUST 28, 2024
Delaware's Supreme Court has upheld a GSK appeal, deciding to review the state’s Superior Court decision to allow expert testimony in Zantac lawsuits.
pharmaphorum
AUGUST 28, 2024
Join the EVERSANA webinar to discover how content transformation is revolutionising pharma marketing strategies. Learn how to shift the paradigm and stay ahead in the industry.
Fierce Pharma
AUGUST 28, 2024
Three years after launching Leqvio in the U.S., Novartis is still steadily advancing its blockbuster ambitions for the cholesterol-lowering drug. | After a positive phase 3 readout, Novartis said it aims to apply cholesterol-lowering Leqvio across the "full spectrum" of atherosclerotic cardiovascular disease.
pharmaphorum
AUGUST 28, 2024
MSD starts phase 3 trial of oral LSD1 inhibitor bomedemstat as a first-line option for blood cancer essential thrombocythaemia
Fierce Pharma
AUGUST 28, 2024
As Stada Arzneimittel’s private equity owners continue to weigh their options around a potential sale or public offering, the German drugmaker gave a good indication Wednesday of exactly what it ca | As Stada Arzneimittel’s private equity owners continue to weigh their options around a potential sale or public offering, the German drugmaker gave a good indication Wednesday of exactly what it can bring to the table.
Advertisement
This new white paper defines and details the impact of Decentralized Clinical Trials on the Pharmaceutical industry and how the impact can be measured along with steps companies can take to ensure adoption.
Pharmaceutical Commerce
AUGUST 28, 2024
In an interview with Pharma Commerce Editor Nicholas Saraceno, Jeb Hunter, Senior Regulatory Consultant, EAS Consulting Group, discusses the on “What to Expect When They’re Inspecting: FDA Inspections on DSCSA Compliance" breakout session at the 2024 HDA Traceability Seminar.
Drug Patent Watch
AUGUST 28, 2024
The European Union (EU) has implemented a robust regulatory framework to ensure the quality and safety of active pharmaceutical ingredients (APIs) used in medicines. The EU’s Good Manufacturing Practice (GMP) guidelines provide the minimum standards for API manufacturing, and compliance with these guidelines is mandatory for all manufacturers and importers of APIs intended for the EU market.
Cloudbyz
AUGUST 28, 2024
Contract Research Organizations (CROs) play a vital role in the life sciences industry, acting as the bridge between pharmaceutical companies and regulatory bodies. They are tasked with managing clinical trials, collecting data, and ensuring that new drugs are safe and effective before they reach the market. Given their critical responsibilities, CROs must have robust pharmacovigilance (PV) systems to monitor and manage adverse events effectively.
Pharmaceutical Commerce
AUGUST 28, 2024
The joint venture aims to disrupt pathological lncRNA interactions with RNA-binding proteins using NextRNA’s platform.
Advertisement
Planning on running clinical trials in Japan? How can you reliably supply these studies? Discover Catalent’s clinical supply packaging facility in Shiga, Japan. Strategically located between Tokyo and Osaka, and one of largest in Japan, this 6,000 square meter facility offers comprehensive services including primary and secondary clinical packaging and labelling, comparator sourcing, cold chain storage, local and global distribution, local language support and white glove service to support stud
Expert insights. Personalized for you.
293 
Let's personalize your content